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Subgroups of patients with angina pectoris and normal
coronary arteries are known to have pacing-induced lac-
tate production and, therefore , myocardial ischemia. To
examine the mechanism of this pacing-induced ischemia,
the effect of incremental atrial pacing on coronary blood
flow and metabolism was studied in 27 patients with
angina and normal coronary arteries. Seventeen patients
continued to exhibit normal lactate extraction even at
heart rates up to 160 beats/min (Group 1), whereas in
10 patients (Group 2) lactate extraction changed to pro-
duction at the highest pacing rate. Coronary blood flow
increased in Group I patients by 18, 41 and 75%, re-
spectively, as heart rate was increased by 20 beat/min
increments from 100 to 160 beats/min . In contrast, coro-
nary blood flow increased by only 8, 7 and 14%, at the
three respective pacing rate s in Group 2.
More than 10% of patients with angina pectoris undergoing
diagnostic coronary angiography have either normal or min-
imally diseased coronary arteries (1,2), The mechanism of
angina in these patients has not been established. Multiple
hypotheses have been proposed to explain this syndrome.
but none, including small vessel disease (3,4). coronary
artery spasm (5-7). oxyhemoglobin dissociation abnormal-
ities (8) and misinterpretation of the coronary angiogram
(9), has been substantiated in the majority of cases. Nor is
there usually evidence of a noncardiac origin of the pain.
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Between the heart rates of 100 and 160 beats/min,
coronary vascular resistance decreased 32% in Group
I patients but was unchanged in Group 2 patients. There
was no significant change in the ratio of myocardial O2
consumption/rate-pressure product in Group 1 patients,
but this ratio decreased from 0.91 ± 0.26 ml
0 2'min -" (mm Hg-beats/min)" to 0.53 ± O.lJ (p <
0.05) in Group 2 patients as heart rate increased from
baseline to 160 beats /min. Thus , patients with angina
and normal coronary arteries who develop ischemia with
pacing have a decreased coronary vasodilator response
that interferes with their ability to increase myocardial
oxygen supply to match the higher demand.
(J Am Coil Cardiol 1987;9:743-51)
The observations by several investigators (10-15) that
myocardial lactate production may occur during stress in
many of these patients with chest pain and normal coronary
arteries suggest that myocardial ischemia can be induced
despite the anatomically normal coronary circulation. Myo-
cardial ischemia occurs when myocardial oxygen supply is
inadequate to meet metabolic needs. Oxygen supply is de-
termined primarily by blood fl ow and oxygen extraction.
Because myocardial oxygen extraction is nearly maximal
even under rest conditions, changes in coronary blood fl ow
are mainly responsible for modifi cations of oxygen supply
to the heart. Normally. changes inmyocardial flowareclosely
linked to alterations in myocardial metabolism so that the
balance between oxygen supply and demand is preserved.
[I' the coronary arterioles that are responsible for autoreg-
ulation were. however, not normally responsive to vaso-
dilatory metabolic stimuli. then possibly this balance would
be upset even in the absence of large vessel obstruction. A
deficien t blood supply would result in myocardial ischemia.
which in turn might provoke chest pain.
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To examine whether patients with chest pain and normal
coronary arteries might have this type of abnormal coronary
physiology, coronary flow and metabolism were studied in
subjects with this syndrome during incremental atrial pac-
ing. The present results are consistent with the postulated
defect in coronary responsiveness and can account for the
presence of myocardial ischemia in many of these patients.
Methods
Study patients. Twenty-seven patients with normal
coronary arteries who had previously undergone diagnostic
coronary angiography for anginal chest pain were studied.
Multiple angiographic views of the coronary arteries and
review of all studies by two experienced angiographers doc-
umented the absence of detectable disease. Informed con-
sent approved by our Institutional Review Board was ob-
tained from all subjects. Beta-adrenergic blocking agents
and calcium entry antagonists were discontinued at least 48
hours and long-acting nitrates at least 24 hours before the
study.
The patients ranged in age from 35 to 68 years (mean
52). Fourteen of the 27 patients were men. All patients had
a history of anginal chest pain. Fourteen patients had only
exertional chest pain and 10 had predominant exertional
symptoms, but also rest pain. The remaining three patients
had predominant rest pain that responded to nitroglycerin.
All patients had continued symptoms despite treatment with
beta-blockers (n = 23) and calcium blockers (n = 7).
Angina was at least partially relieved by nitroglycerin.
Three patients had noninsulin-dependent diabetes. Six-
teen patients had a history of hypertension, but no patient
had a blood pressure at rest greater than 160/90 mm Hg (in
the absence of medication), left ventricular hypertrophy on
electrocardiogram or hypertrophic or congestive cardio-
myopathy by angiography.
The rest electrocardiogram was completely normal in 24
patients; T wave abnormalities were noted in 4 patients and
I patient had right bundle branch block. Electrocardio-
graphic stress tests were performed in 11 patients and 8
had a positive test. Echocardiograms obtained in 10 patients
with a systolic murmur did not demonstrate either mitral
valve prolapse or hypertrophic cardiomyopathy.
Coronary angiography had been performed in the week
preceding the present study in 26 patients, and within 7
months in the remaining patient. All 27 patients had normal
coronary arteries, and the 8 patients receiving intravenous
ergonovine had no evidence of coronary spasm including
those patients with predominant rest pain. No patient had
angiographic or clinical evidence of mitral valve prolapse.
The left ventricular contraction pattern was normal in all,
and the mean left ventricular ejection fraction was 73 ±
10%.
Study protocol. The Ganz thermodilution coronary blood
flow catheter (16) (Wilton Webster Laboratories) was in-
serted percutaneously and positioned in the great cardiac
vein in 20 patients, and positioned in the coronary sinus so
that the external thermistor was at least 2 em from the ostium
in the remaining 7 patients. In 17 of the former patients
only great cardiac vein flows were monitored, whereas in
3 both great cardiac vein and coronary sinus blood flows
could be measured with the Pepine-modified catheter (17),
which has two external thermistors, the distal one in the
great cardiac vein and the proximal one in the coronary
sinus. Catheter position was determined by injection of a
small volume of Renografin, and stable catheter position
was confirmed by fluoroscopy during the procedure. The
multi-purpose Ganz catheter allowed for coronary blood
flow measurement and blood sampling as well as atrial pac-
ing. An 18 gauge Teflon catheter (Abbott Laboratories) was
positioned in the brachial or femoral artery and was used
for measurement of blood pressure and blood sampling.
Coronary blood flow was determined by the continuous
thermodilution technique using the Wilton Webster bridge
(16). Nonheparinized normal saline solution was infused
into the coronary sinus or great cardiac vein at a constant
rate of 60 ml/rnin for 15 to 20 seconds. At least triplicate
measurements of coronary blood flow were made. The elec-
trocardiogram and blood pressure were recorded continu-
ously with an Electronics for Medicine YR 12 multichannel
oscillographic recorder. Heparinized blood samples for ox-
ygen saturation and content were analyzed with a CO-ox-
imeter 282 (Instrumentation Laboratory Inc.) Lactate de-
terminations were performed in duplicate (coefficient of
variance = 2.9%; n = 3I) on deproteinated blood collected
in perchloric acid and analyzed by an enzymatic method
(18) or using Stat-Pack Rapid lactate test kits (Calbiochem
Behring).
Baseline measurements of hemodynamic variables and
coronary sinus or great cardiac vein flow or both, and col-
lection of arterial and coronary venous blood samples for
oxygen and lactate determinations were made in all patients.
Atrial pacing was started at 100 beats/min in patients with
a rest heart rate of <90 beats/min and was increased in
increments of 20 beats/min until either the patient experi-
enced moderately severe chest pain or a maximal heart rate
of 160 beats/min was reached. In patients with an initial
heart rate of >90 beats/min, the first pacing rate was set at
120 beats/min. Intravenous atropine (0.4 to 0.8 mg) was
given to some patients at the higher pacing rates because
of the appearance of Wenckebach atrioventricular (AY) block.
Each pacing rate was maintained for at least 5 minutes at
the end of which hemodynamic and coronary blood flow
measurements were repeated. Blood samples were also col-
lected for oxygen saturation determinations. At the maximal
pacing rate attained additional aliquots of arterial and coro-
nary venous blood were obtained for lactate determinations.
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All measurements and blood sampling were repeated im-
mediately after discontinuation of atrial pacing.
Calculations. Lactate extraction was expressed as (lac.,
- lac
" v
)/(Iaca,t), where lac., and lac., represent lactate con-
tents of arterial and coronary venous blood, respectively.
Myocardial lactate production during or immediately after
pacing was considered an ischemic response. Lactate ex-
traction was calculated from the highest coronary sinus lac-
tate content achieved either during or immediately after
pacing. Coronary vascular resistance was defi ned as BP/CBF
where BP is mean arterial pressure and CBF is coronary
blood flow. Myocardial oxygen consumption (MV02 ) was
determined from the Fick equation as CBF x (At h -
CVo), where Ao, and CVo, are arterial and coronary venous
oxygen content, respectively. Rate-pressure product was
defined as systolic arterial pressure X heart rate (HR x
SBP). For the 20 patients whose great cardiac vein fl ow
was measured, the ratio of myocardial oxygen consumption
to rate-pressure product IMV0 2/(HR x SBPlI was calcu-
lated at each heart rate as an index of the myocardial oxygen
supply/demand ratio.
Statistical anal ysis. All results are presented as means
± SD except as noted. The signifi cance of differences of
arterial lactate levels and lactate extractions at rest and dur-
ing pacing was determined by the Student's paired 1 test.
Neuman-Keuis multiple range testing (19) was used to test
the significance of changes in variables measured at multiple
heart rates. Differences were considered to be signifi cant if
the probability (P) value was < 0.05.
Comparisons between groups were made by the Student' s
unpaired 1 test. When simultaneous comparisons were made
between groups at multiple heart rates, a conservative crit-
ical value of p < 0.0 I was used to test signifi cance based
on the Bonferroni method (20).
Results
Lactate data and group definitions (Fig. 1). Seventeen
patients did not demonstrate lactate production at any time
during the study. These patients are designated as Group I.
Ten patients had lactate production (coronary sinus or great
cardiac vein lactate level greater than arterial lactate level)
either during or immediately after discontinuation of pacing.
These 10 patients constitute Group 2. Mean baseline arterial
lactate concentration averaged 6.8 ± 3.4 rng/dl, in Group
I and 5.6 ± 2.0 mg/dl in Group 2 (p = NS). Mean arterial
lactate levels did not change at the peak atrial pacing rate
(Group I, 6.6 ± 2.5: Group 2, 5.1 ± 1.7). Lactate ex-
traction decreased during pacing from 0.25 ± 0.20 to 0. 19
± 0. 12 in Group I patients (p < 0.05). In Group 2 patients
baseline lactate extraction (0.08 ± 0.(8) changed to lactate
production ( - 0. 15 ± 0. 12) (p < OJ)I) with pacing.
The two groups were similar with respect to age (52 ±
9 and 54 ± 10 years). and quality and duration of chest
pain. Lactate production with pacing tended to be more
common in women than in men (46 versus 28%: p = NS).
The left ventricular ejection fraction was slightly higher in
Group I patients (0.76 ± 0.07 versus 0.67 ± 0. 12: p <
0.05). The left ventricular end-diastolic pressure was similar
in the two groups (Group I: 14.1 ± 6.9 mm Hg: Group 2:
15.1 ± 4.6). The change in rate-pressure product was not
different between the two groups (baseline versus pacing at
160 beats/min: Group I. 14 .0 ± 2.0 versus 22.3 ± 3.4 x
10' beats/min-rnm Hg: Group 2. 14.9 ± 1.9 versus 24. 1
± 2.7 x 10 ' .
Coronary blood flowand vascular resistance. Twenty-
three patients had a rest heart rate of < 90 beats/min and II
of these had a heart rate of < 70 beats/min. Two patients.
one in each group. could be paced to a heart rate of only
Base li ne At rial
Pa c ing
Group 1 I
Group 2 .
-
Figure l. Changes inarterial lactate concentrationand
myocardial lactate metabolismduring pacing . Tailsof
arrows represent measurements during baseline state .
and heads of arrows represent data at highest pacing
rate or immediately after discontinuation of atrial pac-
ing. Group I or normal responders continued to extract
lactate during atrial pacing. whereas Group 2 patients
changed from lactate extraction at rest to production
during pacing. Lac; and LaCey = lactate content of
arterial and coronary venous blood, respectively.
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Table 1. Pacing-Induced Hemodynamic and Metabolic Changes in Patients With Normal
Coronary Arteries
HR (beats/min)
140 160
135 :!: 42 154 :!: 42
123 :!: 26 124 :!: 22
109 :!: I I 112 :!: I I
118 :!: 6 120 :!: 13
11.2 :!: 1.7 11.2 ± 1.9
10.7 :!: 1.1 10.7 :!: 1.0
0.92 :!: 0.36 0.80 :!: 0.30
0.99 :!: 0.24 0.99 :!: 0.21
15.3 :!: 5.1 17.2 :!: 5. 1
11.8:!:2.8 12.2 ± 3.4
120
114 :!: 36
128 ± 43
107 :!: I I
11 3 ± 18
13.5 ± 4.6
12.0 ± 3.6
100
103 ± 12
110 ± 12
11.3 ± 4.0
11.0 ± 2.3
80
Great cardiac vein blood flow* (ml/min)
L ( - ) 86 :!: 30 98 ± 35
L(+) 81 ± 14 113:!: 25
Blood pressure (mm Hg)
L( - ) 97 ± 8
L(+) 101 ± 4
Ao,-CVo, (vol%l
L( -) 11.8 ± 1.8 11.6 ± 1.8 11.7 ± t.3
L(+ l 11.3 ± 1.3 11.1 ± 1.3 10.7 ± 1.3
Anterior LV wall regional vascular resistance (mm Hg/rnl-rnin I l
L( -) 1.30 ± 0.53 1.21 ± 0.46 1.06 :!: 0.39
L( + ) 1.28 ± 0.24 1.03 ± 0.21 0.96 ± 0.33
MVO, (ml O,/min)
L ( - ) 10.1 :!: 3.8
L(+) 9.1 ± 1.6
*Data from the 20 patients in whom great cardiac vein flow was measured. Ao,-CVu, = difference in
oxygen content betweenarterial and great cardiac vein blood; LV = left ventricular; L(- ) and L(+) = lactate
extractors ( - ) or producers (+) at the highest pacing rate or immediately after discontinuation of pacing;
MVO, = myocardial oxygen consumption.
120 beats/min because of chest pain, whereas development
of Wenckebach heart block unresponsive to atropine admin-
istration in two other Group I patients at a pacing rate of
140 beats/min prevented further rate increases. All the other
19 patients were paced to a maximal heart rate of 160
beats/min. Nine of the 10 patients in Group 2 developed
chest pain during atrial pacing, but 10 of the 17 Group I
patients also had chest pain. In five of these Group I patients
the pain was described as mild (grade 1/4), and in two
patients the pain disappeared despite continued pacing at
higher rates.
The effect of increasing heart rate on hemodynamics and
regional blood flow, regional coronary vascular resistance
and arterial-great cardiac vein oxygen difference in the 20
120 140
Heart Rate (bpm)
Figure 2. Change in coronary blood flow (CBF) for
all 27 patients(great cardiac vein in 20; coronary sinus
in 7). Coronary blood flow is normalized to the flow
at 100beats/min [CBFl1(xn]. Thus, each bar graph dem-
onstrates percent increase or decrease in flow at 20
beat/min increments. *p < 0.05; **p < 0.01compared
with previous pacing rate.
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Figure 3. Changes in coronary vascular resistance
(CYR) for all patients normalized to the coronary
vascular resistance at 100 beats/min I CYRII I~ IlJ .
Symbols as in Figure 2.
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patients (14 Group I and 6 Group 2) whose great cardiac
vein flow was measured is shown in Table I . Great cardiac
vein flow rose incrementally in Group I patients as heart
rate increased from 80 to 160 beats/min. InGroup 2 patients.
all of whom produced lactate with pacing, great cardiac vein
flow reached a plateau at the higher pacing rates. After
pacing, heart rate and great cardiac vein flows increased
slightly from baseline in both groups, probably in response
to atropine. which was given during pacing to facilitate AV
node conduction (baseline versus postpacing: Group I. 75
± 12 versus 82 ± 17 beats/min [p < 0.05J and 81 ± 30
versus 92 ± 25 mllmin [p < 0.05]. respectively; Group 2,
68 ± 7 versus 81 ± 7 beats/min [p < 0.05J and 75 ± 18
versus 92 ± 11 ml/min [p = NSJ). Arterial-great cardiac
vein oxygen difference did not change with pacing. Mean
arterial pressure rose slightly in both groups of patients.
The effect of heart rate on coronary bloodflow measured
in either the coronary sinus or the great cardiac vein is more
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Figure 4. Changes in myocardial oxygen con-
sumption (MVOz) for all patients normalized to
the MVOz at 100 beats/min [MVOZIIOllll . Sym-
bols as in Figure 2.
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Figure S. The ratio of myocardial oxygen consumption (MV02)
to the rate-pressure (double) product (DP) as an index of the myo-
cardial oxygen supply-demand relation. The ratio was calculated
for the 20 patients whose great cardiac vein flow was measured.
Although Group I patients demonstrated a slight decrease between
values at baseline and 100 beats/min (p = NSJ, there was no
further change in this index at higher heart rates. Group 2 patients
demonstrated a progressive decrease in the ratio. *p < 0.05 com-
pared with baseline.
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duced ischemia. In contrast to the normal stepwise increase
in coronary blood flow resulting from the metabolic stress
of progressive elevation in heart rate observed in our patients
with a nonischemic response, patients who became ischemic
and produced lactate (Group 2) had a markedly blunted rise
in coronary blood flow with pacing.
It is well accepted that myocardial ischemia is caused by
an imbalance between myocardial oxygen supply and de-
mand. Group 2 patients demonstrated a progressive decrease
in the myocardial oxygen supply/demand ratio as well as
lactate production. Either an increase in myocardial oxygen
demand or a decrease in supply during pacing could lead
to pacing-induced lactate production. Pepine et al. (21) found
an increase in myocardial oxygen demand in patients with
normal coronary arteries and pacing-induced ischemia man-
ifested as an abnormal electrocardiogram or lactate produc-
tion when compared with patients with coronary disease.
In the present study there was no evidence of preferential
increase in myocardial oxygen demand in the patients de-
veloping myocardial ischemia because the rate-pressure
product during pacing was similar in both groups. In ad-
dition, rest ejection fraction in the lactate producers, al-
though normal, was less than in nonproducers. Our data are
consistent with the more probable explanation that the im-
balance of oxygen supply and demand is the result of de-
creased myocardial oxygen supply, which in turn is related
to impaired coronary responsiveness. Other possible causes
of a limited myocardialoxygen supply have been considered
easily appreciated in Figure 2. Because baseline heart rates
varied between 59 and 99 beats/min in the two groups,
coronary blood flow at 100 ± 9 beats/min was considered
to be 100% to facilitate intergroup comparisons. All other
flows in each individual were calculated as a percent of the
observed flow at 100 beats/min. The magnitude of changes
in coronary blood flow for each 20 beat/min increment over
or under 100 beats/min can thus be seen for the entire group.
Coronary blood flow significantly increased in Group I pa-
tients by 18, 41 and 75%, respectively, as the heart rate
was increased by 20 beat/min increments from 100 to 160
beats/min. In contrast, coronary blood flow increased by
only 8, 7 and 14%. respectively, in Group 2 patients. This
blunted response of coronary blood flowduring atrial pacing
in Group 2 patients was related to a relative defect in coro-
nary arteriolar reactivity. Calculated anterior wall regional
vascular resistance (Table I) decreased progressively in Group
I patients from 1.30 ± 0.53 mm Hg-trni/rnin) I at 80
beats/min to 0.80 ± 0.30 at 160 beats/min. Although coro-
nary resistance decreased between heart rates of 80 and 100
beats/min in the lactate producers (Group 2), there was no
further decrease in resistance as pacing rates were increased.
Figure 3 displays changes in coronary vascular resistance
normalized to 100% at a heart rate of 100 beats/min for all
patients. Whereas coronary vascular resistance in Group I
decreased by 32% between the heart rates of 100 and 160
beats/min, there was no change in Group 2 patients.
Myocardial oxygen demand. There was a blunted rise
in calculated myocardial oxygen consumption in Group 2
patients as pacing rate increased. On the other hand, myo-
cardial oxygen consumption increased in a stepwise fash-
ion in Group I patients who had no evidence of ischemia
(Fig. 4).
The effect of atrial pacing on the calculated myocardial
oxygen supply/demand index is demonstrated in Figure 5.
Although in Group I patients there was a slight (p = NS)
decrease in this ratio between baseline heart rate and atrial
pacing at 100 beats/min, the ratio remained constant at higher
pacing rates. In Group 2 patients, there was a progres-
sive decrease in the myocardial oxygen supply/demand
index with a significant decrease from 0.91 ± 0.26 ml
Oy-min I'(mm Hg-beats/min) I at baseline to 0.53 ±
0.11 at 160 beats/min (p < 0.05).
Discussion
Myocardial ischemia and coronary blood flow. The
present results confirm data from previous studies (10-15)
demonstrating that some patients with normal coronary ar-
teries do develop myocardial ischemia as defined by myo-
cardial lactate production. Furthermore, this study demon-
strates an impaired coronary blood flow response to atrial
pacing as a mechanism for the development of pacing-in-
JACC Vol. I) . No.4
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by previous investigators; a defect in oxyhemoglobin as-
sociation has been noted by some (8), but this finding has
not been confirmed by others (22). Furthermore. if myo-
cardial hypoxia related to abnormal oxygen release were the
cause of ischemia, one would expect markedcoronary vaso-
dilation and increased coronary blood flow in an attempt to
compensate for low tissue oxygen concentration. However,
decreased rather than increased coronary flows were ob-
served in our patients. Decreased coronary blood flow due
to coronary spasm is also an unlikelyexplanation for pacing-
induced lactate production . No patients demonstrated ST
segment elevation with chest pain either during pacing or
with spontaneous angina. Eight patients had had a negative
ergonovine test during the diagnostic catheterization, in-
cluding three patients who produced lactate during atrial
pacing. Small vesseldisease (3,4) is an unlikely mechanism
of angina in patients with normal coronary arteries. Endo-
cardial biopsies of both left and right ventricles have usually
shown only nonspecific histologic abnormalities and have
not demonstrated disease of the small (100 to 300 fLm)
vessels (15,23).
Previous studies. Other investigators have looked at the
effect of atrial pacing on coronary blood flow in patients
with angina and normalcoronary arteries. BothOpherk ( 15)
and Berland (24) and their coworkers found no difference
in coronary blood flow response to pacing in " ischemic"
and " nonischernic patients." Their two studies. however,
differed significantly in theirdefinition of " ischemic". Opherk
et al. (15) divided patients into two groups only on the basis
of symptoms of typical or atypical chest pain. In fact. of
21 patients in the allegedly ischemic group with typical
anginal symptoms, lactate metabolism was measured in 8
and lactate production was found in only 3. Berland et al.
(24) defined ischemia as lactate extraction of <9%. This
definition of myocardial ischemia, however, may result in
inclusion of subjects without myocardial ischemia (25) in
the ischemic group. Cannon et at. (26) classified patients
into groups depending on the presence or absenceof pacing-
induced anginal chest pain. There was a blunted increase
in great cardiac vein flow in patients with pacing-induced
angina compared with that in patients without pacing-in-
duced pain (+ 45 ± 30 versus + 86 ± 50%). The present
study differs from that of Cannon et a!. in that all of our
patients had entirely normal coronary arteriescompared with
only 16 of 28 patients in their series. Their remaining 12
patients considered to have normal left anterior descending
coronary artery flow, and therefore normal great cardiac
vein drainage, because the left anterior descending coronary
artery either had nonobstructive «50%) narrowing. had
obstructive changes with a patent coronary bypass graft or
was completely normal despite changes in other coronary
vessels. Furthermore, all patients in our study considered
ischemic responders had lactate production, whereas only
two of the nine patients studied by Cannon et al. who de-
veloped chest pain with pacing and therefore were in the
" ischemic" group produced lactate.
Thus, previous studies examining the relationof coronary
blood flow to heart rate in patients with angina and normal
coronary arteries have found conflicting results. Unfortu-
nately each of the published studies noted has used a dif-
ferent definition for the abnormal or " ischemic" group,
often based on the patient's symptoms. Characterizing pa-
tients on the basis of pretest symptoms of classic or atypical
angina is difficult because many of these patients have both
exertional and rest pain. Similarly, the presence or absence
of chest pain during pacing is subjective. In our study 90%
of patients who produced lactate had chest pain during pac-
ing. Ten of 17 patients. however, who did not produce
lactate also had pain during pacing. In five of those patients,
the pain was described as grade 1/4 and in two additional
patients pain that occurred initially with pacing disappeared
entirely at the higher pacing rates. Thus, classification by
symptoms is considered to be imprecise. Electrocardio-
graphic changes during atrial pacing are difficult to interpret
because of pacer artifact. To classify patients in the present
study lactate production with pacing was considered to be
the only objective evidence of ischemia.
Definition of abnormal lactate metabolism. As noted
by Gertz et at. (25), only lactate production can be consid-
ered as metabolic evidence of ischemia. because either a
decrease inlactate extraction or lactate extraction of < 10%
can occur in normal individuals. One cannot, however, com-
pletely exclude a possible abnormal response in patients who
demonstrated a low myocardial lactate extraction during
atrial pacing. If regional ischemia exists, measurement of
lactate production in one area of the heart may be obscured
by continued normal lactate extraction in a nonischemic
region. Under these conditions net coronary sinus lactate
measurements represent a mixture of venous drainage of
ischemic and nonischemic compartments and, therefore, a
decrease in lactate extraction rather than lactate production
may appear (27). It is not, however, clinically feasible to
establish this type of continuum of lactate abnormalities.
Furthermore. because all of these patients have normalcoro-
nary arteries. regional differences in lactate metabolism are
unlikely. Therefore. despite possible shortcomings. patients
in this study were classified only by the presence or absence
of lactate production.
Mechanism of impaired coronary vascular response.
The mechanism of impaired coronary vascular response to
pacing is yet to be elucidated. Coronary vascular resistance
is mediated by the arteriole and is regulated by a complex
interaction of vascular tone. neurohumoral factors, vaso-
active metabolites and extravascular compression. Either a
decrease in the ability of the coronary arteriole to dilate
(impaired coronary reserve) or an imbalance in the regu-
latory mechanism may be responsible for the abnormal flow
pattern observed. One report (15) has suggested a decrease
750 GREENBERG ET AL.
ANGINA WITH NORMAL CORONARY ARTERIES
JACC Vol. 9. NO. 4
April 1987:743- 51
in coronary reserve in these patients by demonstrating a
decreased coronary dilatory response to intravenous dipyr-
idamole, but this has not been confirmed (24).
Local autoregulatory mechanisms normally adjust to al-
terations in perfusion pressure, neural tone or extravascular
compression. Work by Cannon and coworkers (26,28) sug-
gests that an increase in alpha-adrenergic tone after the cold
pressor test or ergonovine administration or a decrease in
beta-adrenergic tone caused by propranolol can decrease the
anginal threshold in patients with normal coronary arteries.
Mudge et al. (29) demonstrated that an adrenergically me-
diated decrease in coronary vascular resistance in patients
with coronary artery disease may be an important deter-
minant of coronary blood flow and can induce transient
ischemia. Thus, abnormal neurohumoral tone may either
cause or contribute to the observed blunted vascular re-
sponse and may be capable of inducing ischemia both in
patients with and in some patients without coronary artery
disease. Further work on the pathophysiologic mechanism
of the diminished coronary vascular reactivity is needed.
It is unlikely that an increase in extravascular compres-
sion was a cause of thedecreased coronary vascular response
observed in our Group 2 patients. Increased extravascular
compression can be caused by tachycardia or by large in-
creases in either left ventricular end-diastolic pressure or
left ventricular contractility. Heart rate was controlled in
the study and there was no difference in left ventricularend-
diastolic pressure between the groups. The mean ejection
fraction in the Group2 patients, although normal . wasslightly
less than that for the Group I patients.
Conclusions and clinical significance. Patients withan-
gina in the absence of significant coronary obstructive dis-
ease represent a significant number of patients undergoing
diagnostic catheterization. In the Coronary Artery Surgery
Study (CASS) registry(2) 28% of patientshad either normal
coronary arteries or insignificant disease. Even among 500
patients with " defi nite angina" in CASS. 13% had insig-
nificant disease (30). Except in those patients with rest pain
and documented ST segment elevation. the incidence of a
positive ergonovine test in these patients is low (7 ). Despite
increased sophistication in the noninvasive assessment of
chest pain syndromes, including the use of exercise thallium
or wall motion studies, multifactorial analysis and Bayesian
logic. the incidenceof patients with normalcoronary arteries
undergoing cardiac catheterization has not diminished in
recent years (1,2). Indeed, the screening tests themsel ves
may be abnormal in these patients. Both Berger et al. (31)
and Cannon et al. (32) have reported abnormal exercise
radionuclide wall motion studies in subgroups of patients
with angina and normal coronary arteries.
In summary. one-third of the 27 subjects with chest pain
and normal coronary arteries in the present series had both
metabolic evidence of myocardial ischemiaduring the stress
of atrial pacing and an abnormal coronary flow response.
Atrial pacing increases heart rate and hence myocardial ox-
ygen demand. In the normal heart, coronary blood flow
increases to meet this demand. In the subjects whose coro-
nary vasculature failed to dilate appropriately, myocardial
oxygen supply could not match the increased demand, the
myocardial oxygen supply/demand index decreased and
myocardial ischemia ensued. This finding deserves to be
studied in greaterdetail. It is possible that interventions may
be uncovered that can restore the coronary vascular reac-
tivity in these patients and thus abolish ischemiaand relieve
symptoms. Although patients with angina and normal coro-
nary arteries have an excellent prognosis (12,13,33), many
have repeated hospitalizations and disability resulting in
both altered life style and loss of income.
We are indebted to Tada Yipintsoi, MO. PhD for inspiration and help.
Kevin Kramer and James McGinnis for technical assistanceandJanet Ellen
Holwell. Michelle Keappock and Lori Fields for secretarial assistance.
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